Evidence map›Paper›PMID 32663942›Full record

ArticleJournal of affective disorders2020

Electroconvulsive therapy (ECT) for moderate-severity major depression among the elderly: Data from the pride study.

Søren D Østergaard, Maria S Speed, Charles H Kellner, Martina Mueller, Shawn M McClintock, Mustafa M Husain, Georgios Petrides, William V McCall, Sarah H Lisanby, CORE/PRIDE workgroup

Open access · goldAbstract read
In one paragraph

Article in Journal of affective disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Treatment-Resistant Depression in Older Adults.The New England journal of medicine · 2024
    Review
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Søren D ØstergaardDepartment of Affective Disorders, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. Electronic address: soeoes@rm.dk.
Maria S SpeedDepartment of Affective Disorders, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark.
Charles H KellnerIcahn School of Medicine at Mount Sinai, New York, NY, USA; Medical University of South Carolina, Charleston, SC, USA.
Martina MuellerMedical University of South Carolina, Charleston, SC, USA.
Shawn M McClintockDepartment of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.
Mustafa M HusainDepartment of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.
Georgios PetridesThe Zucker Hillside Hospital, Northwell Health System, Glen Oaks, NY, USA; Hofstra Northwell School of Medicine, Hempstead, NY, USA.
William V McCallDepartment of Psychiatry and Health Behavior, Medical College of Georgia, Augusta University, GA, USA.
Sarah H LisanbyNational Institute of Mental Health, Bethesda, MD, USA.
CORE/PRIDE workgroup
Aarhus University · DKMedical University of South Carolina · USAugusta University · USDuke University · USHofstra University · USNational Institute of Mental Health · USThe University of Texas Southwestern Medical Center · US

Funding

Non-invasive Neuromodulation Unit (NNU)ZIAMH002955 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI ZARATE, CARLOS · 2016 to 2025
$40.3M
2/8-Prolonging Remission in Depressed Elderly (PRIDE)U01MH084241 · NIMH · DUKE UNIVERSITY · PI WEINER, RICHARD D. · 2009 to 2013
$2.1M
1/8-Prolonging Remission in Depressed Elderly (PRIDE)U01MH055495 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KELLNER, CHARLES H · 2009 to 2013
$2.0M
3/8-Prolonging Remission in Depressed Elderly (PRIDE)U01MH081362 · NIMH · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KNAPP, REBECCA GRANT · 2009 to 2013
$1.8M
7/8-Prolonging Remission in Depressed Elderly (PRIDE)U01MH086127 · NIMH · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MCCALL, WILLIAM VAUGHN · 2009 to 2013
$1.1M
6/8-Prolonging Remission in Depressed Elderly (PRIDE)U01MH086120 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI HUSAIN, MUSTAFA M. · 2009 to 2013
$1.1M
8/8-Prolonging Remission in Depressed Elderly (PRIDE)U01MH086122 · NIMH · WEILL MEDICAL COLL OF CORNELL UNIV · PI YOUNG, ROBERT C. · 2009 to 2013
$1.0M
5/8-Prolonging Remission in Depressed Elderly (PRIDE)U01MH086130 · NIMH · MAYO CLINIC ROCHESTER · PI SAMPSON, SHIRLENE MARIE · 2009 to 2011
$610k
NIMH NIH HHS U01 MH055495NIMH NIH HHS U01 MH081362NIMH NIH HHS U01 MH084241NIMH NIH HHS U01 MH086120NIMH NIH HHS U01 MH086122NIMH NIH HHS U01 MH086127NIMH NIH HHS U01 MH086130
6 · The paper itself

Abstract

backgroundElectroconvulsive therapy (ECT) is usually reserved for treatment of severe major depressive disorder (MDD), but may be equally effective in the treatment of moderate-severity MDD. This possibility, however, has only been studied to a very limited extent. We therefore investigated the efficacy of ECT after stratifying patients into severe MDD and moderate-severity MDD.

methodsWe used data from the Prolonging Remission in Depressed Elderly (PRIDE) study, in which 240 patients (≥60 years) with MDD were treated with right unilateral ultrabrief pulse ECT, combined with venlafaxine. We used the six-item core depression subscale (HAM-D

resultsAmong the participants with severe MDD and moderate-severity MDD, the mean change in the HAM-D LIMITATIONS: The PRIDE study was not designed to address this research question.

conclusionsECT combined with venlafaxine appears to be an effective treatment for moderate-severity MDD. It may be appropriate to expand the indications for ECT to include patients with moderate-severity MDD.

Indexed as

Electroconvulsive TherapyMajor Depressive DisorderAgedDepressionHumansTreatment OutcomeVenlafaxine HydrochlorideVenlafaxine Hydrochloride

Identifiers

PMID32663942
PMCPMC7363967
OpenAlexW3027810696

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.